2025 annual financial data
DiaMedica Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -34,397,000 USD and net income was -32,766,000 USD.
Operating cash flow was -29,062,000 USD.
Get free DiaMedica Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,397,000 USD
- Net income
- -32,766,000 USD
- Operating cash flow
- -29,062,000 USD